Tune Therapeutics is orchestrating the power of the epigenome to treat complex, pervasive diseases that have long eluded treatment, and to unlock the full potential of regenerative medicine.
Tune is pioneering a new therapeutic modality that can fine-tune any gene network. In breaking free from the limitations of traditional gene and cell therapies, Tune is developing solutions for even the most challenging and intractable diseases – and building the capacity to transform human health and medicine.
Based in Durham, NC. and Seattle, WA., Tune was founded and built around a veteran leadership team with deep expertise in gene and cell therapy, genome editing, and epigenetics.
Learn more about our team of scientists and experts as well as opportunities at the company.
Chief Executive OfficerRead More
Co-Founder, Acting Chief Scientific OfficerRead More
Co-Founder, President, and CFORead More
Vice President, Head of ResearchRead More
Executive Vice President, Head of TechOpsRead More
Vice President, Human ResourcesRead More